Position in XGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$609,816
-$229,224 QoQ
Shares Held
203,272
+47.3% QoQ
Ownership
0.841%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $770,315,587 across 28 Diagnostics & Research names. XGN ranks #21 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
504,668 | $242,336,526 | |
| 2 | DHR |
Danaher Corp /De/
|
678,808 | $128,701,996 | |
| 3 | ILMN |
Illumina, Inc.
|
972,642 | $119,887,852 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
138,964 | $68,304,974 | |
| 5 | NTRA |
Natera, Inc.
|
197,500 | $39,498,025 | |
| 6 | A |
Agilent Technologies, Inc.
|
300,300 | $34,228,194 | |
| 7 | GH |
Guardant Health, Inc.
|
337,600 | $31,184,112 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
48,504 | $27,253,912 |
All Filings in XGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $609,816 | 203,272 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $839,040 | 138,000 | Shares | Sole | 2026-02-12 | |
| 2025-06-30 | $146,580 | 21,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $491,112 | 136,800 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $637,697 | 155,536 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $542,604 | 175,600 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $171,505 | 94,234 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $77,525 | 48,758 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $90,521 | 45,488 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||